New Prime Minister Kim Boo-kyum said Friday that the government would speed up vaccinating beyond the targeted 13 million people in the first half-year to relax its social distancing system from July 1.Kim said that the government would lead the public to follow infection control rather than stickin
Daewoong Pharmaceutical said Friday that it has confirmed the safety and efficacy of the repeated, long-term administration of its botulinum toxin (BTX) product, Nabota, or Jeuveau as called in the U.S., in the follow-up of phase 2 trials conducted in America, Canada, and Europe.Some 94.1 percent of
Novartis Korea said Friday that the Ministry of Food and Drug Safety has approved Piqray (ingredient: alpelisib) for treating menopausal patients with advanced breast cancer through combined use with fulvestrant.The drug can be prescribed to menopausal women with breast cancer whose tumors have PIK3
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. On the occasion of its fourth anniversary, Korea Biomedical Review met with up-and-coming CEOs from various healthcare startups to hear about their company and what they believe is going on in Korea's d
A research team at Gangnam Severance Hospital has discovered certain genetic variations raise the risk of cardiovascular disease in patients with hypertension, diabetes, and dyslipidemia.The research team, led by Professor Lee Ji-won from the Department of Family Medicine and Clinical Assistant Prof
Korea’s new virus cases hit the highest level in 15 days, but the nation’s vaccination rate remained far below 10 percent on Thursday.Government officials warned that the number of newly infected patients could spike in the coming days during this “Month of the Family,” even though Buddhism leaders
Korea University Guro Hospital (KUGH) researchers have developed a multiple contrast agent for imaging lung cancer to minimize tissue damage during resection by accurately detecting cancer deep in the lungs.The multi-contrast agent locates cancer deeply hiding in the lungs and minimizes postoperativ
Hanmi Pharmaceutical said that the U.S. Food and Drug Administration has granted the orphan drug designation to its LAPS Triple Agonist (HM15211) for treating idiopathic pulmonary fibrosis (IPF).The company has won 17 orphan drug designations – nine from the U.S. FDA, five from the European Medicine
Seegene released a report on its provisional performance for the first quarter on Wednesday, with its sales and profits jumping more than 300 percent from a year ago.Investors focus their attention on whether the brisk performance will help restore the company’s share prices, which have fallen to le
SK Biopharmaceuticals registered sales of 140 billion won ($126 million), and an operating profit of 75.9 billion won in the first quarter.The company said Wednesday that the sales increase of its antiepileptic drug Xcopri (ingredient: cenobamate) in the U.S. and the first milestone payment of $110
Two Korean pharmaceutical companies are fiercely competing to receive regulatory approval for their biosimilar drugs of Lucentis (ingredient: ranibizumab), a macular degeneration medicine.Chong Kun Dang and Samsung Bioepis have gone all out to develop the drug and are about to commercialize their pr
A research team of the Institute for Basic Science (IBS) said Tuesday that deficiency in protein TANC2, which plays a crucial role in neuronal development, induces autism and impairs brain development. The research team, led by Professor Kim Eun-joon of the Synaptic Brain Dysfunctions Lab at the Kor
HLB Pharmaceutical said Tuesday that its first-line therapy for liver cancer, rivoceranib, has significantly extended the overall survival period in the second phase 3 clinical trials performed in China.The company conducted the studies at 31 hospitals in China with 400 patients. It confirmed rivoce
Handok Pharmaceuticals and CMG Pharmaceutical have agreed to transfer the technology of anticancer drug CHC2014, which targets Pan-TRK inhibitor in solid tumors, to Singapore’s AUM Biosciences for 193.4 billion won ($173 million).The two companies will grant rights to AUM Biosciences to develop, man
Tego Science, a company specializing in cell therapy, said Monday that it has won the U.S. patent for a chemokine-based component that improves skin.The company plans to conduct trials to obtain indications for treating specific skin injuries with the drug candidate that uses chemokine, an active in
GSK has confirmed the efficacy of Trelegy Ellipta (ingredient: fluticasone furoate, umeclidinium, vilanterol) for treating patients with chronic obstructive pulmonary disease (COPD) in phase 4 clinical studies.The company said its new drug would be effective on COPD patients who could not control th
Researchers from Korea and Japan shared the results of innovative approaches to pancreatic beta-cell regeneration in diabetic patients at the 34th Spring Conference hosted by the Korean Diabetes Association on Saturday.Two experts from each country -- Professors Kim Hyeong-seok of Chungnam National
A Seoul National University Bundang Hospital (SNUBH) research team has extended the survival period of pancreatic cancer patients after surgery with tailored adjuvant chemotherapy based on individual biomarkers.The research team, led by Professor Hwang Jin-hyeok of the Internal Medicine Department,
LifeSemantics, a digital healthcare provider, said Friday that it would begin to develop artificial intelligence (AI)-based precision diagnosis solution, Dr. Answer 2.0, which provides tailored disease prediction, diagnosis, treatment, and prognosis.The company will develop the healthcare software w
Genexine said Thursday that it has recorded sales of 33 billion won ($29.3 million) operating profit of 13.1 billion won, and a net profit of 21.3 billion won in the first quarter thanks to its Covid-19 drug technology transfer.The sales in the first quarter increased by 328 percent from 7.7 billion